排序方式: 共有26条查询结果,搜索用时 15 毫秒
1.
2.
Takahashi H Suzuki N Takagi C Ikegame M Yamamoto T Takahashi A Moriyama S Hattori A Sakamoto T 《Zoological science》2008,25(7):739-745
In teleosts, prolactin is involved in calcium regulation, but its role in scale/bone metabolism is unclear. Using the in-vitro system with goldfish scales developed recently, we explored the effects of teleost prolactin, growth hormone, and somatolactin on osteoclasts and osteoblasts. Addition of prolactin at concentrations of 0.01-100 ng/ml reduced osteoclastic activity, partly via osteoclast apoptosis, after 6-18 h incubation. Conversely, growth hormone and somatolactin at a concentration of 100 ng/ml increased osteoclastic activity after 18 h incubation, indicating the specificity of the inhibitory effect of prolactin on osteoclastic activity. On the other hand, these three hormones promoted osteoblastic activity at concentrations of 10-100 ng/ml. The results from this study are the first demonstration of direct effects of prolactin on scale/bone metabolism and osteoclastic activity in a teleost. 相似文献
3.
Evidence for the functional binding in vivo of tumor rejection antigens to antigen-presenting cells in tumor-bearing hosts 总被引:2,自引:0,他引:2
J Shimizu J P Zou K Ikegame T Katagiri H Fujiwara T Hamaoka 《Journal of immunology (Baltimore, Md. : 1950)》1991,146(5):1708-1714
Spleen cells of BALB/c mice bearing a syngeneic CSA1M fibrosarcoma were treated with anti-Thy-1.2 antibody plus C, yielding a T cell-depleted, APC-containing fraction. The APC-containing fraction was first tested for its capacity to present exogenous modified-self or another tumor (Meth A) Ag after in vitro pulsing. The results showed comparable Ag-presenting capacities to those obtained by APC-containing fraction from normal spleen cells, indicating that APC function is not affected in tumor-bearing mice. We next examined whether APC from CSA1M-bearing mice bind endogenously generated CSA1M tumor Ag onto its surfaces to stimulate tumor-specific T cells. Five rounds of inoculation of APC-containing fraction from CSA1M-bearing mice without further in vitro pulsing resulted in the induction of potent anti-CSA1M immune resistance. The involvement of anti-CSA1M T cells in the induction of anti-CSA1M immunity was excluded by the fact that the in vivo immunity was excluded by the fact that the in vivo immunity was delivered by Thy-1+ cell-depleted, but not by Thy-1+ cell-enriched fractions of spleen cells from CSA1M-bearing mice. Moreover, the failure of Sephadex G10-passed spleen cells to deliver anti-CSA1M resistance demonstrated the absolute requirement of APC for inducing the in vivo immunity. Finally, this in vivo resistance was found to be tumor specific, because APC fractions from CSA1M-bearing and Meth A-bearing BALB/c mice induced immune resistance selective against the corresponding tumor cell challenge. These results indicate that APC from tumor-bearing hosts can not only exert unaffected APC function against exogenous Ag, but also function to present tumor Ag generated endogenously in the tumor-bearing state and to produce tumor-specific immunity in vivo. 相似文献
4.
Bowline, a novel protein localized to the presomitic mesoderm, interacts with Groucho/TLE in Xenopus
Kondow A Hitachi K Ikegame T Asashima M 《The International journal of developmental biology》2006,50(5):473-479
Cells in the prospective somite of Xenopus laevis embryos rotate in an orchestrated manner to form a segregated somite. The prospective somite boundaries are prepatterned by gene expressions in the unsegmented presomitic mesoderm (PSM). However, the roles of polarized gene expression in this boundary formation are not well elucidated. Here we identified a novel gene, bowline, which localizes to the anterior halves of S-II, III in the PSM of X. laevis. Bowline associated with corepressor XGrg-4, a Xenopus homolog of Groucho/TLE protein. A WRPW tetrapeptide motif in Bowline was prerequisite for coprecipitation with XGrg-4 and for downregulation of X-Delta-2 by bowline RNA injection. This study indicates that Bowline is a novel protein interacting with Groucho/TLE and may play a role in somitogenesis in X. laevis. 相似文献
5.
WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone 总被引:3,自引:0,他引:3
Nakajima H Kawasaki K Oka Y Tsuboi A Kawakami M Ikegame K Hoshida Y Fujiki F Nakano A Masuda T Wu F Taniguchi Y Yoshihara S Elisseeva OA Oji Y Ogawa H Azuma I Kawase I Aozasa K Sugiyama H 《Cancer immunology, immunotherapy : CII》2004,53(7):617-624
A Wilms tumor gene WT1 is expressed at high levels not only in most types of leukemia but also in various types of solid tumors, including lung and breast cancer. WT1 protein has been reported to serve as a target antigen for tumor-specific immunotherapy both in vitro in human systems and in vivo in murine models. We have shown that mice immunized with WT1 peptide or WT1 cDNA could reject a challenge from WT1-expressing tumor cells (a prophylactic model). However, it was not examined whether WT1 peptide vaccination had the potency to reject tumor cells in a therapeutic setting. In the present study, we demonstrated for the first time that WT1 peptide vaccination combined with Mycobacterium bovis bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) was more effective for eradication of WT1-expressing tumor cells that had been implanted into mice before vaccination (a therapeutic model) compared with WT1 peptide vaccination alone. An intradermal injection of BCG-CWS into mice, followed by that of WT1 peptide at the same site on the next day, generated WT1-specific cytotoxic T lymphocytes (CTLs) and led to rejection of WT1-expressing leukemia or lung cancer cells. These results showed that BCG-CWS, which was well known to enhance innate immunity, could enhance WT1-specific immune responses (acquired immunity) in combination with WT1 peptide vaccination. Therefore, WT1 peptide vaccination combined with BCG-CWS may be applied to cancer immunotherapy in clinical settings.H. Nakajima and K. Kawasaki contributed equally to this study. 相似文献
6.
Kawashima H Ikegame M Shimomura J Ishibashi O Komori T Noda T Ozawa H 《Journal of gravitational physiology : a journal of the International Society for Gravitational Physiology》2000,7(2):P121-P122
Mechanical stress is one of the most potent inducer of bone formation. The mechanism by which cells receive and transduce the signal into osteogenesis, however, remains unknown. Previous studies have demonstrated that mechanical stress causes changes in expression levels of many genes in osteoblasts and osteocytes both in vivo and in vitro. However, none of these changes are specific to bone cells. Moreover it is not clear which types of cells contributed to the increased osteoblasts induced by mechanical stress. The purpose of this study, therefore, was to identify which cells differentiate into osteoblasts and to examine how the expression of genes that are specific to osteogenic cells changes. 相似文献
7.
Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy
Ikegame Y Yamashita K Hayashi S Mizuno H Tawada M You F Yamada K Tanaka Y Egashira Y Nakashima S Yoshimura S Iwama T 《Cytotherapy》2011,13(6):675-685
Background aimsTransplantation of mesenchymal stromal cells (MSC) derived from bone marrow (BM) or adipose tissue is expected to become a cell therapy for stroke. The present study compared the therapeutic potential of adipose-derived stem cells (ASC) with that of BM-derived stem cells (BMSC) in a murine stroke model.MethodsASC and BMSC were isolated from age-matched C57BL/6J mice. These MSC were analyzed for growth kinetics and their capacity to secrete trophic factors and differentiate toward neural and vascular cell lineages in vitro. For in vivo study, ASC or BMSC were administrated intravenously into recipient mice (1 × 105 cells/mouse) soon after reperfusion following a 90-min middle cerebral artery occlusion. Neurologic deficits, the degree of infarction, expression of factors in the brain, and the fate of the injected cells were observed.ResultsASC showed higher proliferative activity with greater production of vascular endothelial cell growth factor (VEGF) and hepatocyte growth factor (HGF) than BMSC. Furthermore, in vitro conditions allowed ASC to differentiate into neural, glial and vascular endothelial cells. ASC administration showed remarkable attenuation of ischemic damage, although the ASC were not yet fully incorporated into the infarct area. Nonetheless, the expression of HGF and angiopoietin-1 in ischemic brain tissue was significantly increased in ASC-treated mice compared with the BMSC group.ConclusionsCompared with BMSC, ASC have great advantages for cell preparation because of easier and safer access to adipose tissue. Taken together, our findings suggest that ASC would be a more preferable source for cell therapy for brain ischemia than BMSC. 相似文献
8.
Nakano A Tsuji D Miki H Cui Q El Sayed SM Ikegame A Oda A Amou H Nakamura S Harada T Fujii S Kagawa K Takeuchi K Sakai A Ozaki S Okano K Nakamura T Itoh K Matsumoto T Abe M 《PloS one》2011,6(11):e27222
Cancer cells eventually acquire drug resistance largely via the aberrant expression of ATP-binding cassette (ABC) transporters, ATP-dependent efflux pumps. Because cancer cells produce ATP mostly through glycolysis, in the present study we explored the effects of inhibiting glycolysis on the ABC transporter function and drug sensitivity of malignant cells. Inhibition of glycolysis by 3-bromopyruvate (3BrPA) suppressed ATP production in malignant cells, and restored the retention of daunorubicin or mitoxantrone in ABC transporter-expressing, RPMI8226 (ABCG2), KG-1 (ABCB1) and HepG2 cells (ABCB1 and ABCG2). Interestingly, although side population (SP) cells isolated from RPMI8226 cells exhibited higher levels of glycolysis with an increased expression of genes involved in the glycolytic pathway, 3BrPA abolished Hoechst 33342 exclusion in SP cells. 3BrPA also disrupted clonogenic capacity in malignant cell lines including RPMI8226, KG-1, and HepG2. Furthermore, 3BrPA restored cytotoxic effects of daunorubicin and doxorubicin on KG-1 and RPMI8226 cells, and markedly suppressed subcutaneous tumor growth in combination with doxorubicin in RPMI8226-implanted mice. These results collectively suggest that the inhibition of glycolysis is able to overcome drug resistance in ABC transporter-expressing malignant cells through the inactivation of ABC transporters and impairment of SP cells with enhanced glycolysis as well as clonogenic cells. 相似文献
9.
Takeshi Harada Shuji Ozaki Asuka Oda Daisuke Tsuji Akishige Ikegame Masami Iwasa Kengo Udaka Shiro Fujii Shingen Nakamura Hirokazu Miki Kumiko Kagawa Yoshiaki Kuroda Shigeto Kawai Kohji Itoh Hisafumi Yamada-Okabe Toshio Matsumoto Masahiro Abe 《PloS one》2013,8(12)
The immunomodulatory drug lenalidomide (Len) has drawn attention to potentiate antibody-dependent cellular cytotoxicity (ADCC)-mediated immunotherapies. We developed the defucosylated version (YB-AHM) of humanized monoclonal antibody against HM1.24 (CD317) overexpressed in multiple myeloma (MM) cells. In this study, we evaluated ADCC by YB-AHM and Len in combination against MM cells and their progenitors. YB-AHM was able to selectively kill via ADCC MM cells in bone marrow samples from patients with MM with low effector/target ratios, which was further enhanced by treatment with Len. Interestingly, Len also up-regulated HM1.24 expression on MM cells in an effector-dependent manner. HM1.24 was found to be highly expressed in a drug-resistant clonogenic “side population” in MM cells; and this combinatory treatment successfully reduced SP fractions in RPMI 8226 and KMS-11 cells in the presence of effector cells, and suppressed a clonogenic potential of MM cells in colony-forming assays. Collectively, the present study suggests that YB-AHM and Len in combination may become an effective therapeutic strategy in MM, warranting further study to target drug-resistant MM clonogenic cells. 相似文献
10.
Yoshiaki Tabuchi Shigehito Wada Mika Ikegame Ayako Kariya Yukihiro Furusawa Nobuhiko Hoshi Tatsuya Yunoki Nobuo Suzuki Ichiro Takasaki Takashi Kondo Yoshihisa Suzuki 《Experimental Animals》2014,63(1):31-44
We have developed an immortalized oral epithelial cell line, ROE2, from fetal transgenic
rats harboring temperature-sensitive simian virus 40 large T-antigen gene. The cells grew
continuously at either a permissive temperature of 33°C or an intermediate temperature of
37°C. At the nonpermissive temperature of 39°C, on the other hand, growth decreased
significantly, and the Sub-G1 phase of the cell cycle increased, indicating that the cells
undergo apoptosis at a nonpermissive temperature. Histological and immunocytochemical
analyses revealed that ROE2 cells at 37°C had a stratified epithelial-like morphology and
expressed cytokeratins Krt4 and Krt13, marker proteins for oral nonkeratinized epithelial
cells. Global-scale comprehensive microarray analysis, coupled with bioinformatics tools,
demonstrated a significant gene network that was obtained from the upregulated genes. The
gene network contained 16 genes, including Cdkn1a, Fos,
Krt13, and Prdm1, and was associated mainly with the
biological process of skin development in the category of biological functions, organ
development. These four genes were validated by quantitative real-time polymerase chain
reaction, and the results were nearly consistent with the microarray data. It is therefore
anticipated that this cell line will be useful as an in vitro model for
studies such as physiological functions, as well as for gene expression in oral epithelial
cells. 相似文献